Table 3.
CC |
L3 |
L5 |
L6 |
L9 |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MD | RD | AD | MD | RD | MD | RD | MD | RD | AD | MD | RD | AD | |||
Group I | CON-HTN | + | |||||||||||||
Group II | CON-HTN | + | + | + | + | + | + | + | + | + | |||||
Group III | CON-HTN | ||||||||||||||
CON | Group I – group II | ||||||||||||||
Group I – group III | + | + | + | + | + | + | + | + | + | + | + | ||||
Group II – group III | + | + | + | + | + | + | + | + | + | + | + | + | + | ||
HTN | Group I – group II | + | + | + | + | + | + | + | + | + | |||||
Group I – group III | + | + | + | + | + | + | + | + | + | + | |||||
Group II – group III |
Significant simple effects (p < 0.05) of the age groups (I, II, III) and disease (CON, HTN) factor is itemized and marked as “+.” FA, fractional anisotropy; MD, mean diffusivity; RD, radial diffusivity; AD, axial diffusivity. Age group I – 25–47 years old, II – 48–56 years old, III 57–71 years old. CC, corpus callosum; L3, cingulum (hippocampus) L; L5, inferior fronto-occipital fasciculus L; L6, inferior longitudinal fasciculus L; L9, uncinate fasciculus.